EPTIFIBATIDE vs ERENUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
EPTIFIBATIDE vs ERENUMAB: Safety Overview
| Metric | EPTIFIBATIDE | ERENUMAB |
|---|---|---|
| Total FAERS Reports | 462 | 1,183 |
| Deaths Reported | 57 | 363 |
| Death Rate | 12.3% | 30.7% |
| Hospitalizations | 143 | 498 |
| Average Patient Age | 57.2 yrs | 45.6 yrs |
| % Female Patients | 30.9% | 93.4% |
| FDA Approval Date | Apr 18, 2017 | N/A |
| Manufacturer | Slate Run Pharmaceuticals, LLC | Amgen Inc |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Discontinued | N/A |